Active

KEPHAS PHARMA

Switched

BE0793326574

Rechtspersoon Private limited company 1 establishment

Rue du Cheval Blanc(LUT) 55, 6238 Pont-à-Celles Detailhandel in farmaceutische producten

Active for

3 year, 10 months

Financials

Financial year 2024

Gross margin

€ 13,925

▼ 55% vs 2023

Profit

Healthy

€ 7,346

▼ 68% vs 2023

Debts

Low

€ 24,071

▲ 17% vs 2023

KEPHAS PHARMA from Pont-à-Celles, company number BE0793326574, closed financial year 2024 with a result of € 7,346 after tax. For that financial year KEPHAS PHARMA recorded a gross margin of € 13,925 and equity of € 33,505. Compared with financial year 2023, the result moved from € 23,160 to € 7,346. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2025.

What happened at KEPHAS PHARMA?

What happened at KEPHAS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: profit of € 7,346 (▼ 68% vs 2023). Source: NBB ↗
  • New establishment in Pont-à-Celles. KBO
  • Pierre Ayelé Atéba became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 23,160 profit in 2023 to € 7,346 profit in 2024.

Paid € 8,233 in corporate taxes since 2023.

Best year ever: 2023, with € 23,160 profit.

A new publication or filing at KEPHAS PHARMA? We notify you, reason included.

Follow KEPHAS PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Pierre Ayelé Atéba
KEPHAS PHARMA

Behind KEPHAS PHARMA is Pierre Ayelé Atéba.

See the full network in the app

Directors

According to the 2024 annual accounts

Pierre Ayelé Atéba

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Cheval Blanc(LUT) 55

6238 Pont-à-Celles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0793.326.574
VAT number
BE 0793.326.574
Registered office
Rue du Cheval Blanc(LUT) 55, 6238 Pont-à-Celles
Names & denominations
KEPHAS PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
7 November 2022
Peppol
Active · Active since 30 Dec 2025
Activities · NACE

Detailhandel in farmaceutische producten

Overige niet-gespecialiseerde detailhandel

Overige vormen van onderwijs

Detailhandel via postorderbedrijven of via internet

Frequently asked questions

What is the enterprise number of KEPHAS PHARMA?
The enterprise number of KEPHAS PHARMA is BE0793326574.
What is the address of KEPHAS PHARMA?
The registered office of KEPHAS PHARMA is located at Rue du Cheval Blanc(LUT) 55, 6238 Pont-à-Celles.
When was KEPHAS PHARMA founded?
KEPHAS PHARMA was founded on 7 November 2022.
What is the main activity of KEPHAS PHARMA?
The main activity of KEPHAS PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does KEPHAS PHARMA have a website?
No website is currently known for KEPHAS PHARMA.
How much profit did KEPHAS PHARMA make in 2024?
KEPHAS PHARMA posted a profit after taxes of € 7,346 in financial year 2024.
What is the revenue of KEPHAS PHARMA?
As a small company, KEPHAS PHARMA is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 13,925.
Where can I find the annual accounts of KEPHAS PHARMA?
KEPHAS PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of KEPHAS PHARMA?
According to the 2024 annual accounts, the directors of KEPHAS PHARMA are: Pierre Ayelé Atéba.
Who owns KEPHAS PHARMA?
Behind KEPHAS PHARMA is Pierre Ayelé Atéba.